My Lords, the amendments seek to prevent the creation, keeping and use of interspecies—or, as we now intend to call them, human admixed—embryos in any research, including into understanding and treating serious diseases and medical conditions. As science has moved forward since then, our understanding of embryo development and embryonic stem cell research has increased significantly. However, new challenges have arisen as our understanding of stem cells has increased. It is now clearer than ever that the challenges facing embryo researchers are more complex than at first perceived, but we are also more confident than ever that at the end of this research there will be new treatments for serious diseases and medical conditions.
The research community and medical charities have in the past 12 months made a considerable effort to cite the need for human admixed embryo research. The shortage of human eggs in particular for use in refining the process of embryonic stem cells has led to calls for the ability to use animal eggs, which are available, as most of us know, in much greater numbers, to create human admixed embryos. This was further reinforced today by a publication from the Academy of Medical Sciences, the Medical Research Council, the Royal Society and the Wellcome Trust, and supported by the Association of Medical Research Charities. In Annexe A, they eloquently highlight the role of different sources of stem cells: embryonic stem cells, foetal stem cells and adult stem cells.
I also remind the House that the granting of peer review funding for stem cell research is equal if you look at embryonic stem cell research versus adult stem cell research. That is extremely important. Peer review funding in this area is highly competitive. There is a strong cohort out there, an international scientific community, which truly believes that there is a tremendous and rich future for research into embryonic stem cells. The joint pre-legislative scrutiny looked at this with the Science and Technology Select Committee of the other place, and both have held inquiries into the ethical and scientific considerations regarding human admixed embryo research. Both have recommended that this research be permitted under the regulation of the HFEA.
The noble Lord, Lord Tebbit, also raised a very important issue about the unnatural nature of research in this area. I agree that there is an unnatural process here. However, we need to remind ourselves that many scientific discoveries are unnatural. That does not necessarily mean that they are bad. A true example, as highlighted by the noble Baroness, Lady Warnock, is IVF. There is nothing natural about IVF, but it has saved many lives.
Human Fertilisation and Embryology Bill [HL]
Proceeding contribution from
Lord Darzi of Denham
(Labour)
in the House of Lords on Tuesday, 15 January 2008.
It occurred during Debate on bills on Human Fertilisation and Embryology Bill [HL].
About this proceeding contribution
Reference
697 c1221 Session
2007-08Chamber / Committee
House of Lords chamberSubjects
Librarians' tools
Timestamp
2023-12-16 02:16:19 +0000
URI
http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_434369
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_434369
In Solr
https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_434369